At a glance
- Originator Solvay
- Class 2 ring heterocyclic compounds; Cyclohexanes; Heart failure therapies
- Mechanism of Action Adenosine A1 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Acute heart failure; Heart failure
Most Recent Events
- 30 Jan 2013 No development reported - Phase-II for Acute heart failure in USA (IV)
- 30 Jan 2013 No development reported - Phase-II for Heart failure in Germany (IV)
- 30 Jan 2013 No development reported - Phase-II for Heart failure in USA (IV)